Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03137316

Enrollment

437

Registered

2017-05-02

Start date

2014-01-01

Completion date

2017-03-01

Last updated

2017-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Nephropathies, Secondary Hyperparathyroidism

Brief summary

The aim of this study is to evaluate the prevalence of secondary hyperparathyroidism among patients with diabetic nephropathy.

Interventions

DIAGNOSTIC_TESTintact parathyroid hormone level

obtain intact parathyroid hormone level from patients records.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* \[1\] Age was above 18 years, \[2\] Patient had diabetic nephropathy which was diagnosed based on the presence of urinary albumin/creatinine ratio (uACR) ≥ 30 mg/gm ± 24 hours' urinary protein measurement ≥ 300 mg/day

Exclusion criteria

* \[1\] patients were already receiving cinacalcet and/or \[2\] patients had undergone neck surgery for parathyroidectomy.

Design outcomes

Primary

Measure	Time frame	Description
intact parathyroid level	within 1 hour from attending in the clinic	intact parathyroid level

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026